Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro
- PMID: 25092143
- PMCID: PMC4262600
- DOI: 10.1038/leu.2014.235
Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.Blood. 2016 Aug 18;128(7):971-81. doi: 10.1182/blood-2015-11-684225. Epub 2016 Jun 22. Blood. 2016. PMID: 27335278 Free PMC article.
-
Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l.Blood. 2013 Mar 28;121(13):2533-41. doi: 10.1182/blood-2012-11-465120. Epub 2013 Jan 29. Blood. 2013. PMID: 23361907 Free PMC article.
-
Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients.J Hematol Oncol. 2012 Mar 7;5:5. doi: 10.1186/1756-8722-5-5. J Hematol Oncol. 2012. PMID: 22397365 Free PMC article.
-
IDH mutations in acute myeloid leukemia.Hum Pathol. 2012 Oct;43(10):1541-51. doi: 10.1016/j.humpath.2012.05.003. Epub 2012 Aug 20. Hum Pathol. 2012. PMID: 22917530 Review.
-
Overview: A New Era of Cancer Genome in Myeloid Malignancies.Oncology. 2015;89 Suppl 1:1-3. doi: 10.1159/000431054. Epub 2015 Nov 10. Oncology. 2015. PMID: 26551625 Review.
Cited by
-
Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions.Semin Hematol. 2015 Jul;52(3):172-83. doi: 10.1053/j.seminhematol.2015.04.003. Epub 2015 Apr 8. Semin Hematol. 2015. PMID: 26111464 Free PMC article. Review.
-
Drugging Chromatin in Cancer: Recent Advances and Novel Approaches.Mol Cell. 2015 Nov 19;60(4):561-70. doi: 10.1016/j.molcel.2015.10.042. Mol Cell. 2015. PMID: 26590715 Free PMC article. Review.
-
SAM/SAH Analogs as Versatile Tools for SAM-Dependent Methyltransferases.ACS Chem Biol. 2016 Mar 18;11(3):583-97. doi: 10.1021/acschembio.5b00812. Epub 2015 Nov 16. ACS Chem Biol. 2016. PMID: 26540123 Free PMC article. Review.
-
Specific patterns of H3K79 methylation influence genetic interaction of oncogenes in AML.Blood Adv. 2020 Jul 14;4(13):3109-3122. doi: 10.1182/bloodadvances.2020001922. Blood Adv. 2020. PMID: 32634241 Free PMC article.
-
Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach.ACS Med Chem Lett. 2017 Feb 14;8(3):338-343. doi: 10.1021/acsmedchemlett.6b00519. eCollection 2017 Mar 9. ACS Med Chem Lett. 2017. PMID: 28337327 Free PMC article.
References
-
- Shih AH, Abdel-Wahab O, Patel JP, Levine RL. The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer. 2012;12:599–612. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous